The Patent Finder

Ri.Med Foundation

14 patents currently held · Updated Nov 15, 2026
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Aug 2033
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 3, 2027
    The maintenance fee for Retrievable Self-Expanding Non-Thrombogenic Low-Profile Percutaneous Atrioventricular Valve Prosthesis (US 11,771,555) comes due Apr 3, 2027. Unpaid by Oct 4, 2027, it lapses early.
  • 1 fee due Sep 10, 2027
    The maintenance fee for Retrievable Self-expanding Non-thrombogenic Low-profile Percutaneous Atrioventricular Valve Prosthesis (US 10,583,004) comes due Sep 10, 2027. Unpaid by Mar 10, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 10,195,252Recruitment of Mensenchymal Cells Using Controlled Release Systems
In force
 · High confidence
In forceHigh confidence
US 11,129,875Osteoarthritis Treatment With Chemokine-Loaded Alginate Microparticles
In force
 · High confidence
In forceHigh confidence
US 12,178,849Autoimmune Disease Treatment With Chemokine-Loaded Alginate Microparticles
In force
 · Medium confidence
In forceMedium confidence
US 10,179,111Treating Soft Tissue via Controlled Drug Release
In force
 · High confidence
In forceHigh confidence
US 11,129,711Double Component Mandrel for Electrospun Stentless, Multi-Leaflet Valve Fabrication
In force
 · High confidence
In forceHigh confidence
US 12,564,492Retrievable Self-Expanding Non-Thrombogenic Low-Profile Percutaneous Atrioventricular Valve Prosthesis
In force
 · Medium confidence
In forceMedium confidence
US 11,318,103Treating Soft Tissue via Controlled Drug Release
In force
 · High confidence
In forceHigh confidence
US 10,583,004Retrievable Self-expanding Non-thrombogenic Low-profile Percutaneous Atrioventricular Valve Prosthesis
In force
 · High confidence
In forceHigh confidence
US 11,045,218Transatrial Access for Intracardiac Therapy
In force
 · High confidence
In forceHigh confidence
US 11,771,555Retrievable Self-Expanding Non-Thrombogenic Low-Profile Percutaneous Atrioventricular Valve Prosthesis
In force
 · High confidence
In forceHigh confidence
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
Also on record, not counted in the 14: 2 patents in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 2 abandoned

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited